Shares of GoHealth, Inc. (NASDAQ:GOCO) have earned an average rating of “Buy” from the thirteen ratings firms that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $20.40.
Several equities research analysts recently issued reports on GOCO shares. Morgan Stanley increased their price objective on GoHealth from $13.00 to $14.00 and gave the stock an “equal weight” rating in a research note on Friday, May 14th. Zacks Investment Research raised GoHealth from a “sell” rating to a “hold” rating in a research note on Monday, May 17th. Truist cut their price target on GoHealth from $26.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, May 13th. Credit Suisse Group cut their price target on GoHealth from $19.00 to $18.00 and set an “outperform” rating for the company in a research note on Monday, May 17th. Finally, Raymond James cut their price target on GoHealth from $15.00 to $14.00 and set an “outperform” rating for the company in a research note on Monday, May 17th.
Shares of NASDAQ GOCO traded down $0.01 during mid-day trading on Friday, hitting $11.37. 8,782 shares of the company traded hands, compared to its average volume of 1,619,174. GoHealth has a 1 year low of $9.82 and a 1 year high of $26.25. The firm has a market cap of $3.65 billion and a PE ratio of -34.15. The company has a quick ratio of 3.22, a current ratio of 3.22 and a debt-to-equity ratio of 0.43. The business’s 50 day moving average is $11.73.
In other GoHealth news, COO Shane E. Cruz sold 75,000 shares of GoHealth stock in a transaction on Monday, April 26th. The stock was sold at an average price of $12.17, for a total value of $912,750.00. Following the completion of the transaction, the chief operating officer now owns 167,843 shares in the company, valued at approximately $2,042,649.31. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Shane E. Cruz sold 62,500 shares of GoHealth stock in a transaction on Tuesday, May 18th. The shares were sold at an average price of $11.61, for a total value of $725,625.00. Following the completion of the transaction, the chief operating officer now owns 155,343 shares of the company’s stock, valued at approximately $1,803,532.23. The disclosure for this sale can be found here. 33.34% of the stock is currently owned by company insiders.
Institutional investors and hedge funds have recently modified their holdings of the business. Norges Bank bought a new position in GoHealth in the 4th quarter valued at $6,830,000. The Manufacturers Life Insurance Company bought a new position in GoHealth in the 1st quarter valued at $25,128,000. Northern Trust Corp raised its position in GoHealth by 3.9% in the 4th quarter. Northern Trust Corp now owns 289,403 shares of the company’s stock valued at $3,953,000 after purchasing an additional 10,930 shares during the last quarter. Arizona State Retirement System bought a new position in GoHealth in the 4th quarter valued at $167,000. Finally, UBS Asset Management Americas Inc. bought a new position in GoHealth in the 4th quarter valued at $395,000. Hedge funds and other institutional investors own 28.83% of the company’s stock.
GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÂInternal; MedicareÂExternal; Individual and Family Plans (IFP) and OtherÂInternal; and Individual and Family Plans and OtherÂExternal.
Featured Article: Do equity income investments outperform growth and income investments?
Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.